QUALITY ASSURANCE

At ILS, our pursuit of quality is not limited to the operational level, but is valuedprocess and procedure at every level of our business.

ILS’s Quality Assurance (QA) system ensures a consistent level of quality, that discrepancies with quality are prevented, and that our products match the specifications required by the customer

ILS’s quality system is divided into 4 areas which are constantly micromanaged: Production, In – process Quality Control, Inspection and Distribution. Each area has unique process and procedure to ensure product consistency.

Production

• Each process of manufacturing and all the facilities are under strict accountability. Control and conform to cGMP standards. Extensive aseptic validation of wide range of filing processes as well as of new existing equipment is routine.
• Good Manufacturing Practice (GMP) is the part of quality assurance.
• In ILS, we take pride in stringent following of specially developed protocols for hygiene, sanitation and processing that are specific to pharmaceutical products. Some of these are:

1. Storage facilities with quarantining of incoming pharmaceutical matter to prevent the spread of microorganisms,
2. Maintenance of segregated areas for different pharmaceutical materials and of appropriate environmental conditions.
3. Production areas controlled for dust, fumes and vapors generated by the processing of these substances,
4. Cleanliness of equipment to avoid microbiological contamination as per US FDA GMP norms.

In process Quality control

• During production operating system, all parameters of products is inspected to manage quality persist.
• Relevant documents of product is maintained each and every step of production to avoid contamination.

Inspections

• Inspections are part of the overall drug quality assurance system. The objective of inspecting pharmaceutical manufacturing facilities is either to enforce Good Manufacturing Practice (GMP) compliance or to provide authorization for the manufacture and importation of specific pharmaceutical products by foreign health ministries and drug administrations.
• ILS frequently conducts both internal and third-party inspections to monitor the quality of both manufacturing facilities and pharmaceutical products in distribution channels, from the point of manufacture to delivery to the recipient, as a means of eliminating the hazard posed by the infiltration of counterfeit drugs.

Distribution:

• The most effective solution fully managed.
• All administrative procedures such as purchasing, customer service and project management are controlled from our offices and warehouses
• Deliveries to other verified customers are made quickly from stock, using trusted forwarders who are able to meet our requirements for temperature maintenance and stock traceability. Secure and timely deliveries are assured, whether the quantity is for one shipping carton or for multiple pallets.
• After dispatch, we routinely track the shipment to the final destination and keep our customers updated on its movements. Proof of Delivery (PODs) are routinely obtained and kept on record.